Urologie nieuws
- Prostate MRI for the detection of clinically significant prostate cancer: Update and future directions
- Multiplexed quantitative proteomics in prostate cancer biomarker development
- Immunotherapy for advanced or metastatic urothelial carcinoma: an abridged Cochrane review
- First?line immunotherapy of metastatic renal cell carcinoma: an updated network meta?analysis including triplet therapy
- Surveillance of non?muscle?invasive bladder cancer with blue?light cystoscopy: a meta?analysis
- Physiotherapy for continence and muscle function in prostatectomy: a randomised controlled trial
- EC grants label extension approval for Astellas' Xtandi for use in additional recurrent early prostate cancer treatment setting
- Peri?operative outcomes following radical prostatectomy in the setting of advanced prostate cancer
- Molecular analysis of archival diagnostic prostate cancer biopsies identifies genomic similarities in cases with progression post?radiotherapy, and those with de novo metastatic disease
- FDA approves ImmunityBio’s Anktiva bladder cancer treatment
- EC approves Pfizer’s Emblaveo for multidrug-resistant infection treatment
- Added value of randomised biopsy to multiparametric magnetic resonance imaging?targeted biopsy of the prostate in a contemporary cohort
- Prior male sling does not affect outcomes of artificial urinary sphincter
- Post?prostatectomy incontinence: a guideline of guidelines
- Translation and validation of a lifestyle questionnaire related to prostate cancer